Clonidine half-life
The 12-hour input is an adult labeling estimate for parent clonidine.
Every curve begins at 100%. No dose or measured body concentration is assumed.
X-axis: elapsed time. Y-axis: modeled percentage of the relative starting point remaining. This is a mathematical visualization, not a personal concentration estimate.
Clonidine: evidence and interpretation notes
What the representative value means
The 12-hour input is an adult labeling estimate for parent clonidine. Renal function, age, formulation, and clinical use can all make a population-specific result differ from the simple curve.
For the interactive chart, HalfLifeDB starts with 12 hours as the representative value for Clonidine. Route, formulation, sampling, and metabolites remain attached to that label instead of being hidden inside the arithmetic.
Clonidine is included because half-life concepts are relevant beyond recreational or controlled substances. It is an alpha-2 agonist with direct medication-label context.
The 12 hour curve provides a representative view of how a once-present amount declines in a first-order model. It is not a blood pressure, withdrawal, or rebound-symptom predictor.
The citations are intentionally narrow: a DailyMed clonidine tablet label and the PubChem compound record.
Clinical use of clonidine depends on indication, dose form, patient factors, and monitoring. HalfLifeDB does not provide medication instructions.
For Clonidine, the curve should be kept separate from blood pressure response and rebound physiology. Pharmacodynamic effects can outlast or diverge from the modeled decline.
What each source contributes
- DailyMed: Clonidine hydrochloride tablet. This product label adds formulation-specific pharmacokinetic context and does not represent every route or product.
- PubChem: Clonidine. This identity record confirms names and compound identity and does not supply a human half-life.
For Clonidine, the numerical model is tied most closely to DailyMed: Clonidine hydrochloride tablet. As a product label, it adds formulation-specific pharmacokinetic context; it does not represent every route or product.
Why there is no range on the chart
This profile plots 12 hours for Clonidine without adding an unsourced high-low band. A single supported center is more honest than manufacturing a range from unrelated routes, populations, or formulations.
InterpretationReading the curve and its category context
Reading this curve
HalfLifeDB uses 12 h as a representative input for Clonidine. In the simplified model, about 25.0% remains after 24 hours and about 3% remains after five half-lives, or roughly 2.5 days.
This is a day-scale half-life. Repeated exposure, timing, and source context start to matter more than a single snapshot of the curve. The curve is relative: it does not estimate a person's measured concentration, effects, impairment, or time to clearance.
alpha-2 agonist context
Alpha-2 agonist interpretation often depends on formulation, central nervous system effects, blood-pressure context, and patient-specific clearance.
- The curve is not a blood-pressure or sedation predictor.
- Rebound, withdrawal, or clinical monitoring questions are outside the model.
- Source context should be checked for product and route.
ComparisonTimeline checkpoints and nearby profiles
Clonidine timeline checkpoints
| Elapsed time | Modeled remaining | Reading note |
|---|---|---|
| 12 h | 50.0% | Meaningful modeled decline, not near-zero |
| 24 h | 25.0% | Long-tail portion of the model |
| 2.0 days | 6.25% | Low modeled remainder, not a clearance guarantee |
| 3.0 days | 1.56% | Low modeled remainder, not a clearance guarantee |
| 5.0 days | 0.10% | Low modeled remainder, not a clearance guarantee |
Nearby profiles by half-life
These entries sit near Clonidine within the alpha-2 agonist group when sorted by representative half-life. That makes them curve comparisons, not statements about equal potency, effects, or risk.
No nearby published profiles are available in this category.
EvidencePharmacokinetic inputs and source trail
Pharmacokinetics at a glance
| Representative half-life | 12 h |
|---|---|
| Curve type | Normalized, first-order decline |
Selection note: The 12-hour input is an adult labeling estimate for parent clonidine. Renal function, age, formulation, and clinical use can all make a population-specific result differ from the simple curve.
Sources and evidence context
A linked record is not automatically proof of the displayed value. Study, labeling, review, and compound identity sources serve different purposes; notes below identify limitations when they are known.
- Official labeling DailyMed label: Clonidine hydrochloride tablet.Official U.S. product labeling used for formulation and labeled pharmacokinetic context; its statements apply to the described product.
- Identity record PubChem Compound Summary: Clonidine.Compound identity and naming record. It supplies chemistry context, not independent numerical support for the model.
BoundariesWhat this page cannot answer and where to continue
What this page does not answer
- It does not estimate impairment, intoxication, or fitness to drive.
- It does not predict urine, blood, saliva, or hair test results.
- It does not model repeated exposure, tolerance, withdrawal, or interactions.
- It does not replace clinician, pharmacist, toxicologist, or emergency guidance.
Continue with context
- All substance profiles
- Browse the alpha-2-agonist group
- Compare this curve
- Clearance and volume of distribution
- Bioavailability, route, and formulation
- Active metabolites and parent compounds
- First-order vs nonlinear kinetics
- Detection windows vs half-life
- Reading labels and source quality
Read the medical disclaimer, methodology, and research standards before using the model for comparison.